Clinical Trials · NCT01408888
A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 29
- Start date
- Aug 2011
- Locations
- 3 sites, United States
- Primary endpoint
- Pharmacokinetics: Area Under the Concentration Versus Time Curve (AUC) of Sitagliptin